Drug profile · INN
leuprolide mesylate
CAMCEVI KIT
leuprolide mesylate (CAMCEVI KIT) is a gonadotropin-releasing hormone receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
Drug details — leuprolide mesylate
- US status
- approved
- Class
- —
- Route
- SUBCUTANEOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
leuprolide mesylate (CAMCEVI KIT) is a gonadotropin-releasing hormone receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Mechanism of action
Gonadotropin-releasing hormone receptor agonist
Primary target: Gonadotropin-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is leuprolide mesylate?
leuprolide mesylate (CAMCEVI KIT) is a gonadotropin-releasing hormone receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for leuprolide mesylate?
CAMCEVI KIT is a marketed brand name for leuprolide mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of leuprolide mesylate?
leuprolide mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.